Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 150,000 | 311,000 | 305,000 | 210,978 | 77,000 |
| Depreciation Amortization | 39,000 | 156,000 | 119,000 | 79,515 | 39,000 |
| Income taxes - deferred | 35,000 | 115,000 | 96,000 | 60,453 | 23,000 |
| Accounts receivable | -81,000 | -224,000 | -173,000 | -256,919 | -154,000 |
| Accounts payable and accrued liabilities | -7,000 | 58,000 | 46,000 | 66,609 | 64,000 |
| Other Working Capital | -83,000 | -183,000 | -166,000 | -256,757 | -162,000 |
| Other Operating Activity | 31,000 | 137,000 | 28,000 | 118,503 | 67,000 |
| Operating Cash Flow | $84,000 | $370,000 | $255,000 | $22,383 | $-46,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40,000 | -188,000 | -144,000 | -89,465 | -42,000 |
| Net Acquisitions | N/A | -4,000 | N/A | N/A | N/A |
| Purchase Of Investment | -343,000 | -1,173,000 | -548,000 | -406,283 | -249,000 |
| Sale Of Investment | 388,000 | 1,025,000 | 640,000 | 479,169 | 215,000 |
| Purchase Sale Intangibles | -68,000 | -19,000 | -15,000 | -11,084 | -2,000 |
| Other Investing Activity | -67,000 | -8,000 | -7,000 | -5,535 | 1,000 |
| Investing Cash Flow | $-62,000 | $-348,000 | $-59,000 | $-22,113 | $-75,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -127,000 | 46,000 | N/A | N/A | 36,000 |
| Common Stock Issued | N/A | 4,000 | 4,000 | 3,794 | 2,000 |
| Dividend Paid | N/A | -55,000 | -56,000 | -55,971 | N/A |
| Other Financing Activity | -10,000 | -27,000 | -49,000 | -14,661 | -8,000 |
| Financing Cash Flow | $-137,000 | $-32,000 | $-101,000 | $-66,839 | $30,000 |
| Exchange Rate Effect | 6,000 | 10,000 | 1,000 | 1,229 | 2,000 |
| Beginning Cash Position | 188,000 | 195,000 | 199,000 | 200,070 | 199,000 |
| End Cash Position | 80,000 | 196,000 | 295,000 | 134,730 | 110,000 |
| Net Cash Flow | $-108,000 | $1,000 | $96,000 | $-65,340 | $-89,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 84,000 | 370,000 | 255,000 | 22,383 | -46,000 |
| Capital Expenditure | -42,000 | -193,000 | -147,000 | -91,544 | -43,000 |
| Free Cash Flow | 42,000 | 177,000 | 108,000 | -69,161 | -89,000 |